Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)
29.15
+0.24 (0.83%)
Oct 15, 2025, 2:45 PM CST
SHA:688687 Revenue
Beijing Kawin Technology Share-Holding had revenue of 334.86M CNY in the quarter ending June 30, 2025, a decrease of -12.77%. This brings the company's revenue in the last twelve months to 1.20B, down -18.54% year-over-year. In the year 2024, Beijing Kawin Technology Share-Holding had annual revenue of 1.23B, down -12.87%.
Revenue (ttm)
1.20B
Revenue Growth
-18.54%
P/S Ratio
4.03
Revenue / Employee
2.00M
Employees
600
Market Cap
4.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.23B | -181.71M | -12.87% |
Dec 31, 2023 | 1.41B | 252.03M | 21.73% |
Dec 31, 2022 | 1.16B | 15.62M | 1.36% |
Dec 31, 2021 | 1.14B | 282.30M | 32.75% |
Dec 31, 2020 | 862.05M | 37.13M | 4.50% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |